Education
About Us
Working with TipRanks
Follow Us
Amicus Therapeutics (GB:0HF9)
:0HF9
Amicus (0HF9) Ownership Overview
1.33% Insiders
28.49% Mutual Funds
37.15% Other Institutional Investors
16.14% ETFs
16.88% Public Companies and Individual Investors
The ownership structure of Amicus (GB:0HF9) stock is a mix of institutional, retail, and individual investors. Approximately 81.79% of the company’s stock is owned by Institutional Investors, 1.33% is owned by Insiders, and 16.88% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 21, 2025 | Bradley Campbell President & Ceo,director | xxxxxxxxxxxxx | $4000 |
| Dec 03, 2024 | Bradley Campbell President & Ceo,director | xxxxxxxxxxxxx | $75075 |
| Nov 07, 2024 | Bradley Campbell President & Ceo,director | xxxxxxxxxxxxx | $98763 |
| Nov 04, 2024 | Bradley Campbell President & Ceo,director | xxxxxxxxxxxxx | $85950 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $2838575 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $8805816 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $228396867 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 27,753,650 | Institution | 9.03% | 258,247,713 | |
| 25,296,679 | Institution | 8.23% | 235,385,598 | |
| 24,245,952 | Institution | 7.89% | 225,608,583 | |
| 18,593,958 | Institution | 6.05% | 173,016,779 | |
| 13,043,961 | Institution | 4.25% | 121,374,057 | |
| 4,793,631 | Institution | 1.56% | 44,604,736 | |
| 4,139,173 | Institution | 1.35% | 38,515,005 | |
| 3,492,476 | Institution | 1.14% | 32,497,489 | |
| 3,308,208 | Institution | 1.08% | 30,782,875 | |
| 3,258,720 | Institution | 1.06% | 30,322,390 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 25,296,679 | Institution | 8.23% | 235,385,598 | |
| 18,593,958 | Institution | 6.05% | 173,016,779 | |
| 4,793,631 | Institution | 1.56% | 44,604,736 | |
| 3,492,476 | Institution | 1.14% | 32,497,489 | |
| 3,308,208 | Institution | 1.08% | 30,782,875 | |
| 3,258,720 | Institution | 1.06% | 30,322,390 | |
| 3,217,275 | Institution | 1.05% | 29,936,744 | |
| 2,718,457 | Institution | 0.88% | 25,295,242 | |
| 2,267,200 | Institution | 0.74% | 21,096,296 | |
| 2,083,691 | Institution | 0.68% | 19,388,745 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Amicus Therapeutics (GB:0HF9)?
According to the latest TipRanks data, approximately 37.15% of the company's stock is held by institutional investors, 1.33% is held by insiders, and 16.88% is held by retail investors.
What percentage of Amicus Therapeutics (GB:0HF9) stock is held by institutional investors?
According to the latest TipRanks data, approximately 37.15% of Amicus Therapeutics (GB:0HF9) stock is held by institutional investors.
What percentage of Amicus Therapeutics (GB:0HF9) stock is held by retail investors?
According to the latest TipRanks data, approximately 16.88% of Amicus Therapeutics (GB:0HF9) stock is held by retail investors.
Who owns the most shares of Amicus Therapeutics (GB:0HF9)?
Vanguard owns the most shares of Amicus Therapeutics (GB:0HF9).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.